EyePoint, Inc. (EYPT) Institutional Ownership

Ownership Summary

EyePoint, Inc. (NASDAQ:EYPT) showed up in the 13F filings of 160 institutional investors as of December 2025.

• These investors collectively held 117.9% of EyePoint's outstanding shares in December 2025, up from 102.0% in September 2025.
• Their total shares held in EYPT increased 22.24% from the prior quarter, while the number of investors in EyePoint increased 11.89% year over year.
• Of these 160 funds, 99 grew their exposure to EyePoint, 36 cut back, and 25 maintained positions.
• Altogether, these fund groups held 82.76Mn shares in EYPT by December 2025, up by 15.06Mn shares quarter on quarter, and up 7.24Mn shares year over year.
• SUVRETTA CAPITAL MANAGEMENT, LLC leads ownership in EYPT with 8.3Mn shares as of December 31, 2025, equal to 11.82% of outstanding shares.
• The most significant purchases of EYPT for the quarter ending December 2025 came from Janus Henderson Group Plc (4.26Mn), VANGUARD CAPITAL MANAGEMENT LLC (3.56Mn), Commodore Capital LP (2.82Mn), CITADEL ADVISORS LLC (1.91Mn), Parkman Healthcare Partners LLC (1.35Mn).
• The biggest sellers of EyePoint for the quarter ending December 2025 included Goldman Sachs Group Inc (1.8Mn), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.4Mn), ORBIMED ADVISORS LLC (1.4Mn), Paradigm Biocapital Advisors LP (549.04K), Schonfeld Strategic Advisors LLC (454.33K).
• According to Business Quant data, leading holders of EYPT for December 2025 are SUVRETTA CAPITAL MANAGEMENT, LLC (8.3Mn), Cormorant Asset Management, LP (8.26Mn), Janus Henderson Group Plc (7.2Mn), BlackRock, Inc. (7.18Mn), Federated Hermes, Inc. (5.67Mn), Franklin Resources Inc (5.05Mn), VANGUARD CAPITAL MANAGEMENT LLC (3.56Mn), ADAGE CAPITAL PARTNERS GP, L.L.C. (3.3Mn), Paradigm Biocapital Advisors LP (3.14Mn), Commodore Capital LP (2.82Mn).